Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carlos H. Moreira is active.

Publication


Featured researches published by Carlos H. Moreira.


HIV/AIDS : Research and Palliative Care | 2016

Leishmaniasis-HIV coinfection: current challenges.

José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos H. Moreira

Leishmaniasis – human immunodeficiency virus (HIV) coinfection can manifest itself as tegumentary or visceral leishmaniasis. Almost 35 countries have reported autochthonous coinfections. Visceral leishmaniasis is more frequently described. However, usual and unusual manifestations of tegumentary leishmaniasis have been reported mainly in the Americas, but the real prevalence of Leishmania infection in HIV-infected patients is not clear. Regarding the clinical manifestations, there are some reports showing unusual manifestations in visceral leishmaniasis and tegumentary leishmaniasis in HIV-infected patients; yet, the usual manifestations are more frequent. Leishmaniasis diagnosis relies on clinical methods, but serological tests are used to diagnose visceral leishmaniasis despite them having a low sensitivity to tegumentary leishmaniasis. The search for the parasite is used to diagnose both visceral leishmaniasis and tegumentary leishmaniasis. Nevertheless, in HIV-infected patients, the sensitivity of serology is very low. Drugs available to treat leishmaniasis are more restricted and cause severe side effects. Furthermore, in HIV-infected patients, these side effects are more prominent and relapses and lethality are more recurrent. In this article, we discuss the current challenges of tegumentary leishmaniasis and visceral leishmaniasis–HIV infection, focusing mainly on the clinical manifestations, diagnosis, and treatment of leishmaniasis.


Revista Da Sociedade Brasileira De Medicina Tropical | 2018

Para-kala-azar dermal leishmaniasis in a patient in Brazil: a case report

José Angelo Lauletta Lindoso; Carlos H. Moreira; Beatriz Julieta Celeste; Luiza Keiko Oyafuso; P M Folegatti; Eduard Evert Zijlstra

Visceral leishmaniasis is common in Brazil and is caused by Leishmania (Leishmania) infantum/chagasi. Post-kala-azar dermal leishmaniasis frequently follows visceral leishmaniasis caused by L. donovani, and para-kala-azar dermal leishmaniasis refers to an uncommon presentation wherein it occurs simultaneously along with visceral leishmaniasis. While post-kala-azar dermal leishmaniasis only occurs occasionally in L. infantum/chagasi infections, it frequently occurs in patients with concomitant immunosuppression (HIV co-infection). Here, we describe the first case of para-kala-azar dermal leishmaniasis in Brazil. It is important to raise awareness of post- and para-kala-azar dermal leishmaniasis in L. infantum endemic areas as these patients may contribute to visceral leishmaniasis transmission.


Arquivos Brasileiros De Cardiologia | 2017

Importance of Clinical and Laboratory Findings in the Diagnosis and Surgical Prognosis of Patients with Constrictive Pericarditis

Fábio Fernandes; Dirceu Thiago Pessoa de Melo; Felix José Alvarez Ramires; Ricardo Ribeiro Dias; Marcio Tonini; Vinicius dos Santos Fernandes; Carlos Eduardo Rochitte; Carlos H. Moreira; Charles Mady

Background International studies have reported the value of the clinical profile and laboratory findings in the diagnosis of constrictive pericarditis. However, Brazilian population data are scarce. Objective To assess the clinical characteristics, sensitivity of imaging tests and factors related to the death of patients with constrictive pericarditis undergoing pericardiectomy. Methods Patients with constrictive pericarditis surgically confirmed were retrospectively assessed regarding their clinical and laboratory variables. Two methods were used: transthoracic echocardiography and cardiac magnetic resonance imaging. Mortality predictors were determined by use of univariate analysis with Cox proportional hazards model and hazard ratio. All tests were two-tailed, and an alpha error ≤ 5% was considered statically significant. Results We studied 84 patients (mean age, 44 ± 17.9 years; 67% male). Signs and symptoms of predominantly right heart failure were present with jugular venous distention, edema and ascites in 89%, 89% and 62% of the cases, respectively. Idiopathic etiology was present in 69.1%, followed by tuberculosis (21%). Despite the advanced heart failure degree, low BNP levels (median, 157 pg/mL) were found. The diagnostic sensitivities for constriction of echocardiography and magnetic resonance imaging were 53.6% and 95.9%, respectively. There were 9 deaths (10.7%), and the risk factors were: anemia, BNP and C reactive protein levels, pulmonary hypertension >55 mm Hg, and atrial fibrillation. Conclusions Magnetic resonance imaging had better diagnostic sensitivity. Clinical, laboratory and imaging markers were associated with death.


American Journal of Tropical Medicine and Hygiene | 2015

BENZNIDAZOLE-RELATED ADVERSE DRUG REACTIONS IN BRAZILIAN PATIENTS WITH CHAGAS DISEASE

Carlos H. Moreira; Noemia Barbosa Carvalho; Rosario Q. Ferrufino; Cristina M. Guastini; José Angelo Lauletta Lindoso; Lea Campos de Oliveira; Erika Regina Manuli; Marcela Souza; Ester C. Sabino


HIV/AIDS : Research and Palliative Care | 2018

Visceral leishmaniasis and HIV coinfection: current perspectives

José Angelo Lauletta Lindoso; Carlos H. Moreira; Mirella Alves Cunha; Igor Thiago Queiroz


European Heart Journal | 2018

P1599A risk score to predict 2-year mortality for chagas cardiomyopathy: analysis of a large population from endemic areas in Brazil

Antonio Luiz Pinho Ribeiro; C.D.L. Oliveira; M C P Nunes; Enrico A. Colosimo; E Malveira; C.S. Cardoso; Lea Campos de Oliveira; A.M. Ferreira; D S Haikal; Carlos H. Moreira; Ana Luiza Bierrenbach; Ester C. Sabino


Archive | 2017

PROGNOSTIC MARKERS OF DEATH FOR CHAGAS DISEASE IN REMOTE AREAS OF BRAZIL

Cláudia Di Lorenzo Oliveira; Ester C. Sabino; Clareci Silva Cardoso; Lea Campos de Oliveira; Ariela Mota Ferreira; Ana Luiza Bierrenbach; Enrico A. Colosimo; Carlos H. Moreira; Marcio K. Oikawa; Edecio C. Neto; Antonio Luiz Ribeiro


American Journal of Tropical Medicine and Hygiene | 2017

USE OF SALIVA FOR LARGE SCALE TRYPANOSOMA CRUZI SCREENING

Lea Campos de Oliveira; Carlos H. Moreira; Claudia D. Lorenzo; Ana Luiza Bierrenbach; Erika Regina Manuli; Natylia B. Pereira; Flavia C. Salles; Marcela Souza-Basquera; Ester C. Sabino


American Journal of Tropical Medicine and Hygiene | 2017

CHAGAS DISEASE: A PROSPECTIVE THERAPEUTIC COHORT WITH 12 MONTHS FOLLOW-UP, ANALYZING ADVERSE DRUG REACTIONS, THERAPEUTIC FAILURE AND SEEKING FOR BIOMARKERS""

Carlos H. Moreira; Noemia Barbosa Carvalho; Rosario Q. Ferrufino; Lea Campos de Oliveira; José Angelo Lauletta Lindoso; Erika Regina Manuli; Marcela Souza; Ester C. Sabino


American Journal of Tropical Medicine and Hygiene | 2017

CIRCULATING MIRNAS PROFILE AS POTENTIAL SIGNATURE OF BENZNIDAZOLE TREATMENT TOXICITY IN CHAGAS PATIENTS

Darlan da Silva Candido; Edecio Cunha-Neto; Vagner Oliveira-Carvalho Rigaud; Lea Campos de Oliveira; Carlos H. Moreira; Nelson Gaburo Junior; Marcela Souza; Ester C. Sabino; Ludmila R. P. Ferreira

Collaboration


Dive into the Carlos H. Moreira's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ana Luiza Bierrenbach

Universidade Federal de Goiás

View shared research outputs
Top Co-Authors

Avatar

Charles Mady

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Enrico A. Colosimo

Universidade Federal de Minas Gerais

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge